Clinical Trials · NCT03710889
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Radius Health, Inc.
- Enrollment
- 23
- Start date
- Sep 2018
- Locations
- 4 sites, United States
- Primary endpoint
- Change From Baseline in Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Envelope at Month 3